“You Never Know What You’re Getting”: Opioid Users’ Perceptions of Fentanyl in Southwest Pennsylvania

References

• American Communities Project. (n.d.). Residential segregation. Retrieved from https://doi.org/https://s4.ad.brown.edu/projects/diversity/segregation2010/Default.aspx
   Google Scholar
• Bancroft, A., & Scott Reid, P. (2016). Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge. International Journal of Drug Policy, 35, 42–49. doi:10.1016/j.drugpo.2015.11.008
   Google Scholar
• Bee, C. A. (2013). The Geographic Concentration of High-Income Households: 2007–2011 (American Community Survey Briefs). Washington, D.C.: U.S. Census Bureau.
   Google Scholar
• Bell, A., Bennett, A. S., Jones, T. S., Doe-Simkins, M., & Williams, L. D. (2018). Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Substance Abuse. doi:10.1080/08897077.2018.1449053
   PubMedGoogle Scholar
• Carroll, J. J., Marshall, B. D. L., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. International Journal of Drug Policy, 46, 136–145. doi:10.1016/j.drugpo.2017.05.023
   PubMed Web of Science ®Google Scholar
• Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017). Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin.’. International Journal of Drug Policy, 46, 146–155. doi:10.1016/j.drugpo.2017.06.004
   PubMed Web of Science ®Google Scholar
• Dombrowski, K., Khan, B., Wendel, T., McLean, K., Misshula, E., & Curtis, R. (2012). Estimating the size of the methamphetamine-using population in New York City using network sampling techniques. Advances in Applied Sociology, 2(4), 245–252. doi:10.4236/aasoci.2012.24032
   PubMedGoogle Scholar
• Drug Enforcement Administration. (2017a). 2017 National drug threat assessment (No. DEA-DCT-DIR-040-17).
   Google Scholar
• Drug Enforcement Administration. (2017b). Analysis of overdose deaths in Pennsylvania, 2016 (No. DEA-PHL-DIR-034-17).
   Google Scholar
• Frank, R. G., & Pollack, H. A. (2017). Addressing the Fentanyl Threat to Public Health. New England Journal of Medicine, 376(7), 605–607. doi:10.1056/NEJMp1615145
   Google Scholar
• Gladden, R. M., Martinez, P., & Seth, P. (2016). Fentanyl law enforcement submissions and increases in synthetic opioid–involved overdose deaths — 27 states, 2013–2014. Morbidity and Mortality Weekly Report, 65(33), 837–843. doi:10.15585/mmwr.mm6533a2
   PubMed Web of Science ®Google Scholar
• Harris, M., Forseth, K., & Rhodes, T. (2015). “It’s Russian roulette”: Adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage. International Journal of Drug Policy, 26(1), 51–58. doi:10.1016/j.drugpo.2014.09.009
   PubMed Web of Science ®Google Scholar
• Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations studying hidden populations. Social Problems, 44(2), 174–199. doi:10.2307/3096941
   Web of Science ®Google Scholar
• Kalton, G. (2009). Survey quality. Component of Statistics Canada Catalogue no. 12-001-X Business Survey Methods Division Article, Ottawa, Canada.
   Google Scholar
• Krieger, M. S., Yedinak, J. L., Buxton, J. A., Lysyshyn, M., Bernstein, E., Rich, J. D., …., Marshall, B. D. L. (2018). High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal, 15, 7.
   PubMed Web of Science ®Google Scholar
• Lewis, N., Ockerman, E., Ochenbach, J., & Lowery, W. (2017, August 15). Fentanyl linked to thousands of urban overdose deaths. The Washington Post. Retrieved from https://www.washingtonpost.com/graphics/2017/national/fentanyl-overdoses/?utm_term=.ef9189de49bc
   Google Scholar
• Macmadu, A., Carroll, J. J., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2017). Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addictive Behaviors, 68, 35–38. doi:10.1016/j.addbeh.2017.01.014
   PubMed Web of Science ®Google Scholar
• Malekinejad, M., Johnston, L. G., Kendall, C., Kerr, L. R. F. S., Rifkin, M. R., & Rutherford, G. W. (2008). Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior, 12(S1), 105–130. doi:10.1007/s10461-008-9421-1
   Web of Science ®Google Scholar
• Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2016). The textures of heroin: User perspectives on “Black Tar” and powder heroin in two U.S. cities. Journal of Psychoactive Drugs, 48(4), 270–278. doi:10.1080/02791072.2016.1207826
   PubMed Web of Science ®Google Scholar
• Mars, S. G., Ondocsin, J., & Ciccarone, D. (2018). Sold as heroin: Perceptions and use of an evolving drug in Baltimore, MD. Journal of Psychoactive Drugs, 50, 167–176. doi:10.1080/02791072.2017.1394508
   PubMed Web of Science ®Google Scholar
• McGowan, C. R., Harris, M., Platt, L., Hope, V., & Rhodes, T. (2018). Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it? International Journal of Drug Policy, 58, 31–36. doi:10.1016/j.drugpo.2018.04.017
   Google Scholar
• McKnight, C., & Des Jarlais, D. C. (2018). Being “hooked up” during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. International Journal of Drug Policy, 60, 82–88. doi:10.1016/j.drugpo.2018.08.004
   PubMed Web of Science ®Google Scholar
• Mema, S. C., Sage, C., Popoff, S., Bridgeman, J., Taylor, D., & Corneil, T. (2018). Expanding harm reduction to include fentanyl urine testing: results from a pilot in rural British Columbia. Harm Reduction Journal, 15(1), 19. doi:10.1186/s12954-018-0224-z
   PubMedGoogle Scholar
• O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017). Deaths involving fentanyl, fentanyl analogs, and U-47700 — 10 States, July–December 2016. Morbidity and Mortality Weekly Report, 66(43), 1197–1202. doi:10.15585/mmwr.mm6643e1
   PubMed Web of Science ®Google Scholar
• OverdoseFreePA. (n.d.). Overdose death data. Retrieved from https://doi.org/https://www.overdosefreepa.pitt.edu/know-the-facts/view-overdose-death-data/
   Google Scholar
• Rhodes, T. (2009). Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20(3), 193–201. doi:10.1016/j.drugpo.2008.10.003
   PubMed Web of Science ®Google Scholar
• Somerville, N. J., O’Donnell, J., Gladden, R. M., Zibbell, J. E., Green, T. C., Younkin, M., … Walley, A. Y. (2017). Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016. MMWR. Morbidity and Mortality Weekly Report, 66(14), 382–386. doi:10.15585/mmwr.mm6614a2
   Google Scholar
• United States Centers for Disease Control. (2016). Retrieved from https://www.cdc.gov/drugoverdose/data/fentanyl-le-reports.html#_edn1
   Google Scholar
• United States Centers for Disease Control. (n.d.). Underlying cause of death, 1999-2016 request. Retrieved from https://wonder.cdc.gov/ucd-icd10.html
   Google Scholar
• World Health Organization, R O. for the E. M. (2013). Introduction to HIV/AIDS and sexually transmitted infection surveillance: Module 4: Introduction to respondent-driven sampling. Retrieved from http://apps.who.int/iris/handle/10665/116864
   Google Scholar